Recruiting Scleroderma Studies in Washington D.c.
Platform Clinical Study for Conquering Scleroderma
The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung ...
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lun...
About Scleroderma Clinical Trials in Washington D.c.
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 2 scleroderma clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 700 participants. Research is being sponsored by Scleroderma Research Foundation, Inc., GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Washington D.c. — FAQ
Are there scleroderma clinical trials in Washington D.c.?
Yes, there are 2 scleroderma clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.c.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.
Are clinical trials in Washington D.c. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 2 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov